Veneno Technologies is a Tsukuba City, Japan-based company focused on research and development of peptide DRPs for ion channels, transporters, GPCRs and other membrane proteins. Its core product is Veneno Suite™, a proprietary integrated DRP drug discovery technology that includes a large gene library created by artificially accelerating the evolution of natural Disulfide Rich Peptides (DRPs), a fast screening system, and technology for efficient production of various DRPs. The company generates its library by using natural DRPs as templates and accelerating their evolution. Veneno plans to use new funding to strengthen recruitment and organizational structure and to further develop its peptide drug discovery platform technology. It also intends to invest in research and development of its own drug discovery pipeline using DRP functional peptides as basic molecules to advance DRP drug discovery. The company raised seed financing to support these development and R&D efforts.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Jan 2022